SCHEMBL2786155

SCHEMBL2786155

CC1CCCCC12COC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29314660 1.00 — —
SCHEMBL16659516 0.85 — —
SCHEMBL7529686 0.79 — —
SCHEMBL23505340 0.79 MAPT (0.32) —
SCHEMBL15927296 0.79 — —
SCHEMBL16659517 0.77 — —
SCHEMBL15546449 0.76 — —
SCHEMBL17348570 0.74 — —
SCHEMBL1218895 0.74 — —
SCHEMBL16666909 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023195530-A1 URACIL DERIVATIVE HAVING VIRAL GROWTH INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME 塩野義製薬株式会社 2023-10-12 — — WO disclosed
EP-4257137-A2 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVES FOR THE TREATMENT OF HIV Shionogi & Co., Ltd (JP) 2023-10-11 — — EP disclosed
EP-4249077-A1 NOVEL ACRIDINIUM SALT AND METHOD FOR PRODUCING SAME Shionogi & Co., Ltd (JP) 2023-09-27 — — EP disclosed
EP-3495363-B1 NITROGEN-CONTAINING CONDENSED RING COMPOUNDS HAVING DOPAMINE D3 RECEPTOR ANTAGONISTIC EFFECT SHIONOGI & CO (JP) 2023-08-23 — — EP disclosed
US-20230227454-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2023-07-20 — — US disclosed
US-20230227454-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2023-07-20 — — US disclosed
WO-2023090411-A1 PHARMACEUTICAL FOR TREATING HEART DISEASE OR SKELETAL MUSCLE DISEASE 塩野義製薬株式会社 2023-05-25 — — WO disclosed
EP-4122926-A1 TRIAZINE DERIVATIVE HAVING VIRUS PROPAGATION INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Shionogi & Co., Ltd (JP) 2023-01-25 — — EP disclosed
EP-3290424-B1 SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF SHIONOGI & CO (JP) 2023-01-04 — — EP disclosed
EP-3412663-B1 NITROGEN-CONTAINING HETEROCYCLE AND CARBOCYCLE DERIVATIVES HAVING TRKA INHIBITORY ACTIVITY SHIONOGI & CO (JP) 2022-09-07 — — EP disclosed
US-20100233621-A1 PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) 2010-09-16 — — US disclosed
EP-2218715-A1 PHOTOACID GENERATOR AND PHOTOREACTIVE COMPOSITION Sumitomo Seika Chemicals CO. LTD. (JP) 2010-08-18 — — EP disclosed
EP-1237983-B1 POLYMERIZABLE COMPOSITION, CURED MATERIAL THEREOF AND METHOD FOR MANUFACTURING THE SAME SHOWA DENKO KK (JP) 2007-08-01 — — EP disclosed
US-6783840-B2 FOR PRODUCING PRINTED CIRCUIT BOARD SHOWA DENKO K.K. (JP) 2004-08-31 — — US disclosed
US-20030022958-A1 Resist ink composition SHOWA DENKO K.K. (JP) 2003-01-30 — — US disclosed
US-20020161068-A1 Polymerizable composition, cured material thereof and method for manufacturing the same SHOWA DENKO K.K. (JP) 2002-10-31 — — US disclosed
EP-1237983-A2 POLYMERIZABLE COMPOSITION, CURED MATERIAL THEREOF AND METHOD FOR MANUFACTURING THE SAME Showa Denko K.K. (JP) 2002-09-11 — — EP disclosed
EP-1222496-A1 RESIST INK COMPOSITION Showa Denko K.K. (JP) 2002-07-17 — — EP disclosed
WO-2002008347-A2 RESIST INK COMPOSITION SHOWA DENKO K. K. (JP) 2002-01-31 — — WO disclosed
WO-2001083580-A2 POLYMERIZABLE COMPOSITION, CURED MATERIAL THEREOF AND METHOD FOR MANUFACTURING THE SAME SHOWA DENKO K. K. (JP) 2001-11-08 — — WO disclosed
Send feedback